NCT06222905 is a clinical trial of non interventional in Cystic Fibrosis, sponsored by Papworth Hospital NHS Foundation Trust.

Who is sponsoring NCT06222905?

NCT06222905 is sponsored by Papworth Hospital NHS Foundation Trust.

What drugs are being tested in NCT06222905?

Interventions in NCT06222905: non interventional.

What condition does NCT06222905 study?

NCT06222905 studies Cystic Fibrosis.

Is NCT06222905 still recruiting?

NCT06222905 is currently active, enrolled. Last updated 31 May 2025.

Last reviewed 2025-05-31 · How we verify

NCT06222905

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)

Active, enrolled Last updated 31 May 2025

What this trial tests

trial testing non interventional in Cystic Fibrosis in 475 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

20 February 2019

Primary endpoint
25 January 2024

31 December 2030

Quick facts

Lead sponsor	Papworth Hospital NHS Foundation Trust
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	475
Start date	20 February 2019
Primary completion	25 January 2024
Estimated completion	31 December 2030
Sites	2 locations across United Kingdom

Drugs / interventions tested

non interventional

Conditions studied

Cystic Fibrosis — all drugs for Cystic Fibrosis →

Sponsor

Papworth Hospital NHS Foundation Trust

Who can join

Adults 18 to 80, any sex, with Cystic Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the impact of home monitoring in adults with cystic fibrosis. The main questions it aims to answer are: * how people with CF find using home monitoring equipment * to see if by using home monitoring data acute respiratory exacerbations (chest infections) can be detected earlier than standard care Participants will be provided with a range of home monitoring equipment - * hand held spirometer (lung function) * weighing scales * oximeter (blood oxygen levels) * activity and heart rate monitor to measure health at home several times a week. This information links to an app on a smartphone which the participant and clinicians can see.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy.
Milczewska J, Syunyaeva Z, Żabińska-Jaroń A, Sands D, et al · · 2024 · cited 15× · PMID 39631927 · DOI 10.1183/16000617.0068-2024

Verify or expand the search:

Other trials of non interventional

Trials testing the same drug.

NCT05362123 — Survey on the Effectiveness of the PLAB Examination in Continuing Clinical Education in British Doctors. · completed
NCT05116956 — SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort Study · unknown
NCT04406363 — Confinement Effect on Low Back Pain Intensity in Chronic Low Back Pain Patients · unknown
NCT04068363 — Donor Gender Effect on Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant · completed
NCT01595295 — Registry on Hypomethylating Agents in Myeloid Neoplasms · completed

Other recruiting trials for Cystic Fibrosis

Currently open trials in the same condition.

NCT07437105 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants · Phase 1 · recruiting
NCT07283770 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants · Phase 1 · recruiting
NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
NCT06810167 — Assessing Tenapanor as a Treatment of CF-related Constipation. · Phase 3 · recruiting
NCT06962852 — A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI · Phase 1, PHASE2 · active not recruiting

Other Papworth Hospital NHS Foundation Trust trials

Trials by the same sponsor.

NCT07289100 — Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchie · recruiting
NCT06433960 — Radial Artery Assessment in Surgical Coronary Revascularisation · completed
NCT05775263 — Validation of UK Protocols to Exclude Brain Blood Flow During Normothermic Regional Perfusion (NRP) · unknown
NCT06421792 — PrOtamIne doSing clOt imagiNg (POISON) Study · not yet recruiting
NCT06072872 — Portable Continuous Positive Airways Pressure (CPAP) in Excessive Central Airway Collapse (ECAC) Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06222905 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Papworth Hospital NHS Foundation Trust
Last refreshed: 31 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06222905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing